In this video, hear from Jon Riek, PhD, Vice President, Musculoskeletal & Metabolic Imaging, Philips Pharma Solutions, about DXA (dual-energy X-ray absorptiometry) for bone mineral density testing.
DXA remains the gold standard test for bone mineral density assessments. In clinical trials, outside of bone-related conditions and treatments, DXA scans can be used to ensure that a treatment is not having an unintended impact on bone integrity. Could their use become more widespread in clinical trials, akin to cardiac safety testing?
Hear more about how DXA scans work, who should get one and their use in trials.
Watch the video here:
Register for our free featured webinar with Philips Pharma Solutions here: https://xtalks.com/webinars/imaging-in-clinical-trials-pitfalls-and-promises/
This piece was created in collaboration with sponsoring company Philips Pharma Solutions and the Xtalks editorial team.